Neurology Market Research Reports
The notion “neurology” refers to a branch of medical scientific study dealing with central, peripheral and autonomic nervous systems, and their structure, functions and disorders, in particular. Companies involved in the neurology market produce a wide range of neurology devices. Neurology devices represent the largest and the most promising segments of the medical devices market.
In late 2016, the worldwide neurology devices market is expected to be over USD 7 billion. The largest neurology devices market is the USA, followed by Japan. Boston Scientific Corporation, DePuy Inc., CareFusion Corporation, Accuracy Inc. are amid major industry participants.
Research reports available in the Catalogue include data on the neurology devices market. The reports provide the profiles of the key vendors in the market space; analyses of trends factors affecting the market and forces contributing to the industry growth. The research studies evaluate the competitive landscape and future industry projections.
Pituitary ACTH Hypersecretion (Cushing's Disease) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic ...
Apr, 2013 43 pages... key players involved in the therapeutic development for Neuropathy. Neuropathy - Pipeline Review, Half Year is built using data and information sourced ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons ...
Apr, 2013 77 pages... reviews key players involved in the therapeutic development for Essential Tremor. Essential Tremor - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons ...
Apr, 2013 32 pages... market for the period 2010 – 2018 and gives a forecast of the market from 2012 – 2018, considering 2011 as the base year. The ... is categorized into the following segments: Nephrology & Urology Devices Market by Device Segment Dialysis Equipment Hemodialysis Peritoneal Dialysis Urinary Stone Treatment ...
Apr, 2013 91 pages... the Americas, and the EMEA and APAC regions; it covers the Global Deep Brain Stimulator market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space are Boston Scientific Corp., ...
Apr, 2013 37 pages... could pose a challenge to the growth of this market. TechNavio's report, Global Neurostimulation Devices Market 2012-2016, has been prepared based on an in-depth ... . The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space are Medtronic Inc., ...
Apr, 2013 37 pages... of 7.98 percent over the period 2012-2016. One of the key factors contributing to this market growth is the huge patient population with various neurological disorders. The Intraoperative Neuromonitoring market in the US has also been witnessing the trend of increasing mergers and acquisitions. ...
Feb, 2013 38 pagesIn 2011, the total European market for neurological devices was valued at €628.3 million. Market growth will be driven by the continued acceptance of ... hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that ...
Mar, 2013 410 pages... and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022'. ... have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant ...
Feb, 2013 136 pages... and Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022'. ... have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant ...
Feb, 2013 135 pages... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022'. ... impact of key events as well the drivers and restraints affecting Spain Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...
Feb, 2013 129 pages... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022'. ... impact of key events as well the drivers and restraints affecting Japan Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...
Feb, 2013 135 pages... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022'. ... impact of key events as well the drivers and restraints affecting Italy Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...
Feb, 2013 132 pages... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022 ... , a growing middle class with better healthcare access, and increased epilepsy treatment in the whole population. However, loose government regulation of patent ...
Feb, 2013 128 pages... Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022 ... is the launch of generics and the high rate of generic substitution in Germany. In addition, strict government pricing restrictions will limit the the ...
Feb, 2013 136 pages... Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 ... impact of key events as well the drivers and restraints affecting France Epilesy market. REASONS TO BUY Understand and capitalize by identifying products ...
Feb, 2013 130 pages... Market Analysis to 2022 SUMMARY GlobalData has released its new Country report, 'PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022'. ... general population, which drives the growth of the prevalent population of epilepsy patients, the AED market is fairly large, despite the relatively ...
Feb, 2013 114 pagesEpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2022 SUMMARY Alzheimer’s disease is the most common cause of dementia in people age 60 years and ... for care of persons affected with the disease. SCOPE The Alzheimer’s disease EpiCast Report provides an overview of the risk factors and ...
Feb, 2013 42 pages... specialist, has released its new report, 'Amyotrophic Lateral Sclerosis – Analysis and Market Forecasts to 2019'. The report is an essential source of information ... key markets. Pipeline candidates fall under major therapeutic classes. Analysis of the current and future competition in the seven key countries ...
Jan, 2013 75 pages... ’s new report, “Micromed S.p.A Market Share Analysis” provides in-depth information on Micromed S.p.A’s market position in the neurological diagnostic equipments market. The report ... (in Revenues) information for the neurological diagnostic equipments market. All the key data-points are for 2011 and cover all ...
Jan, 2013 22 pages
